NEGVAC
- May 28, 2021
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
NEGVAC
Subject : Science & tech
Context : the government is still examining the American pharma giant’s request for indemnity against the cost of compensation for any severe side effects, Dr V K Paul ,who also heads the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), said.
Concept :
National Expert Group on Vaccine Administration(NEGVAC)
- NEGVAC constituted by the government is providing guidance on prioritisation of population groups, procurement and inventory management, vaccine selection and vaccine delivery and tracking mechanism
- It was set up in August 2020 under the chairmanship of Niti Aayog member VK Paul, to conceptualise a strategy for coronavirus vaccine delivery in India.
- The expert committee held its first meeting on August 12 of this year.
- The meeting was chaired by Dr V K Paul, Member Niti Aayog along with Secretary (Ministry of Health and Family Welfare) as co-Chair.
- National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) in consultation with State Governments and all relevant stakeholders have prepared and presented a detailed blueprint of vaccine storage, distribution, and administration.
- The Expert Group in consultation with the States is working actively on vaccine prioritization and distribution of vaccine.